in these complexes. Further, the complexes 1–5 have been proven to catalyse the transferhydrogenation of linear, cyclic and aromatic ketones to their corresponding secondary alcohols in the presence of i-PrOH/KOH at 82 °C and the maximum conversion is up to 99%. The effect of other variables on the transferhydrogenation reaction such as solvent, base, temperature, time and catalyst loading is also
Synthesis, structural characterization, electrochemistry and catalytic transfer hydrogenation of ruthenium(II) carbonyl complexes containing tridentate benzoylhydrazone ligands
作者:Rupesh Narayana Prabhu、Rengan Ramesh
DOI:10.1016/j.jorganchem.2012.08.002
日期:2012.11
metal-to-ligand charge transfer (MLCT) transitions in the visible region and display one quasi-reversible reduction and two irreversible oxidations. Further, the catalytic efficiency of the complexes has been investigated in the case of transferhydrogenation of ketones to the corresponding secondary alcohols. The influence of base, reaction temperature and catalyst loading in transferhydrogenation reaction was
方便合成八种具有通式[Ru(L)(CO)(EPh 3)2 ](其中E = P或As; H 2 L =苯甲酰hydr配体,两个H's )的八面体钌(II)羰基苯甲酰hydr络合物描述了两个可解离的质子)。取代的苯甲酰hydr配体表现为双阴离子三齿O,N和O供体(L),并通过酚盐氧,偶氮甲碱氮和去质子化的酰胺氧与钌配位。配合物的组成已通过元素分析和光谱方法(FT-IR,1 H NMR,13 C NMR,UV-vis)确定。配合物之一[Ru(L2)(CO)(PPh 3)的晶体结构2 ](2)已通过单晶X射线晶体学解决,表明这些配合物中存在八面体几何形状的扭曲。所有的配合物在可见光区域都表现出金属到配体的电荷转移(MLCT)跃迁,并显示出一种准可逆的还原反应和两种不可逆的氧化反应。此外,在将酮转移氢化为相应的仲醇的情况下,已经研究了配合物的催化效率。还评估了碱,反应温度和催化剂在转移加氢反应中的影
Palladium complexes catalyzed regioselective arylation of 2-oxindole via in situ C(sp2)−OH activation mediated by PyBroP
作者:A. Vignesh、Werner Kaminsky、N. Dharmaraj
DOI:10.1016/j.jorganchem.2016.09.026
日期:2016.12
Pd(II) complexes appended with ONO pincer type ligand were synthesized, structurally characterized and successfully applied as catalysts for regieoselective C−2 arylation of 2-oxindole via in situ C (sp2)−OH activation in aqueous-organic media under an open atmosphere at room-temperature. This catalyst was reused up to four cycles. Favourably, the present protocol doesn't require the addition of any
methods, and single crystal X-ray crystallographic technique. The new and reusable homogeneous catalyst has been effectively applied to the Mizoroki–Heck reaction of activated and deactivated arylbromides with various olefins under mild reaction conditions in good to excellent yields up to 99%.
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells
作者:Chao Chen、Naveen K. Dolla、Gabriele Casadei、John B. Bremner、Kim Lewis、Michael J. Kelso
DOI:10.1016/j.bmcl.2013.12.015
日期:2014.1
Current antibiotics for treating Clostridium difficile infections (CDI), that is, metronidazole, vancomycin and more recently fidaxomicin, are mostly effective but treatment failure and disease relapse remain as significant clinical problems. The shortcomings of these agents are attributed to their low selectivity for C. difficile over normal gut microflora and their ineffectiveness against C. difficile spores. This Letter reports that certain diarylacylhydrazones identified during a high-throughput screening/counter-screening campaign show selective activity against two Clostridium species (C. difficile and Clostridium perfringens) over common gut commensals. Representative examples are shown to possess activity similar to vancomycin against clinical C. difficile strains and to kill stationary-phase C. difficile cells, which are responsible for spore production. Structure-activity relationships with additional synthesised analogues suggested a protonophoric mechanism may play a role in the observed activity/selectivity and this was supported by the well-known protonophore carbonyl cyanide m-chlorophenyl hydrazone (CCCP) showing selective anti-Clostridium effects and activity similar to diarylacylhydrazones against stationary-phase C. difficile cells. Two diarylacylhydrazones were shown to be non-toxic towards human FaDu and Hep G2 cells indicating that further studies with the class are warranted towards new drugs for CDI. (C) 2013 Elsevier Ltd. All rights reserved.